Literature DB >> 2495950

Nosocomial pneumonia in the intubated patient: role of gastric colonization.

D E Craven1, F D Daschner.   

Abstract

A high rate of nosocomial pneumonia exists among intubated patients receiving mechanical ventilation. Retrograde colonization of the oropharynx and trachea with bacteria from the stomach is not widely appreciated in the pathogenesis of pneumonia. Gastric colonization is affected by age, malnutrition, antibiotics, disease of the gastrointestinal tract, and changes in pH. The widespread use of antacids and/or histamine type 2 blockers as prophylaxis against stress bleeding in the ventilated patient may also increase gastric pH and the risk of colonization in the upper gastrointestinal tract. Migration of bacteria between the stomach, oropharynx and trachea in the intubated patient may be a dynamic system involving large numbers of bacteria. The high fatality rate of mechanically ventilated patients with pneumonia, which persists despite treatment of these patients with appropriate antimicrobial therapy, underscores the need for effective measures of prevention. Preventive measures include the appropriate use of antibiotics, proper decontamination of respiratory therapy equipment, the cautious use of drugs that alter the natural gastric acid barrier, or, possibly, the selective use of antibiotics to prevent or reduce gastric, oropharyngeal and tracheal colonization.

Entities:  

Mesh:

Year:  1989        PMID: 2495950     DOI: 10.1007/bf01964119

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  65 in total

1.  OPPORTUNISTIC GRAM-NEGATIVE ROD PULMONARY INFECTIONS.

Authors:  M H LEPPER
Journal:  Dis Chest       Date:  1963-07

2.  The bacterial flora of gastric lavages from patients undergoing partial gastrectomy.

Authors:  H SCHWABACHER; A J SALSBURY; T G LOOSEMORE
Journal:  J Clin Pathol       Date:  1959-11       Impact factor: 3.411

3.  Nosocomial infection surveillance, 1984.

Authors:  T C Horan; J W White; W R Jarvis; T G Emori; D H Culver; V P Munn; C Thornsberry; D R Olson; J M Hughes
Journal:  MMWR CDC Surveill Summ       Date:  1986

Review 4.  Aerobic gram-negative bacillary pneumonias.

Authors:  A K Pierce; J P Sanford
Journal:  Am Rev Respir Dis       Date:  1974-11

5.  Evidence suggesting importance of role of interbacterial inhibition in maintaining balance of normal flora.

Authors:  K Sprunt; W Redman
Journal:  Ann Intern Med       Date:  1968-03       Impact factor: 25.391

6.  Prevention of acute stress bleeding with sucralfate, antacids, or cimetidine. A controlled study with pirenzepine as a basic medication.

Authors:  M Tryba; F Zevounou; M Torok; M Zenz
Journal:  Am J Med       Date:  1985-08-30       Impact factor: 4.965

Review 7.  Bacterial adherence to respiratory tract mucosa--a dynamic interaction leading to colonization.

Authors:  H Y Reynolds
Journal:  Semin Respir Infect       Date:  1987-03

8.  Pharyngeal aspiration in normal adults and patients with depressed consciousness.

Authors:  E J Huxley; J Viroslav; W R Gray; A K Pierce
Journal:  Am J Med       Date:  1978-04       Impact factor: 4.965

9.  Antacid versus cimetidine in preventing acute gastrointestinal bleeding. A randomized trial in 75 critically ill patients.

Authors:  H J Priebe; J J Skillman; L S Bushnell; P C Long; W Silen
Journal:  N Engl J Med       Date:  1980-02-21       Impact factor: 91.245

10.  Studies on the intestinal flora. II. Bacterial flora of the small intestine in patients with gastrointestinal disorders.

Authors:  B S Drasar; M Shiner
Journal:  Gut       Date:  1969-10       Impact factor: 23.059

View more
  11 in total

1.  Dose-dependent rate of nosocomial pulmonary infection in mechanically ventilated patients with brain oedema receiving barbiturates: a prospective case study.

Authors:  K E Eberhardt; B M Thimm; A Spring; W R Maskos
Journal:  Infection       Date:  1992 Jan-Feb       Impact factor: 3.553

2.  Is it safe to use preprepared endotracheal tubes in the resuscitation room?

Authors:  A Bleetman; N Ashwood
Journal:  J Accid Emerg Med       Date:  1996-07

Review 3.  Review of available trials of selective decontamination of the digestive tract (SDD).

Authors:  H K van Saene; C P Stoutenbeek; A A Gilbertson
Journal:  Infection       Date:  1990       Impact factor: 3.553

Review 4.  Prevention of hospital-acquired pneumonia in critically ill patients.

Authors:  D H Hamer; M Barza
Journal:  Antimicrob Agents Chemother       Date:  1993-05       Impact factor: 5.191

Review 5.  The pathogenesis of ventilator-associated pneumonia: I. Mechanisms of bacterial transcolonization and airway inoculation.

Authors:  R J Estes; G U Meduri
Journal:  Intensive Care Med       Date:  1995-04       Impact factor: 17.440

6.  Selective digestive decontamination in multiple trauma patients: cost and efficacy.

Authors:  A Langlois-Karaga; M Bues-Charbit; A Davignon; J Albanese; O Durbec; C Martin; N Morati; G Balansard
Journal:  Pharm World Sci       Date:  1995-01-27

7.  Prevention of nosocomial infection in critically ill patients by selective decontamination of the digestive tract. A randomized, double blind, placebo-controlled study.

Authors:  L A Rocha; M J Martín; S Pita; J Paz; C Seco; L Margusino; R Villanueva; M T Durán
Journal:  Intensive Care Med       Date:  1992       Impact factor: 17.440

8.  Role of selective digestive decontamination (SDD) in the prevention of nosocomial pneumonia (NP): is gastric decontamination necessary?

Authors:  A E Martinez-Pellús; J Ruiz; J Garcia; M T San Miguel; G Seller; M Bru; C Palazon
Journal:  Intensive Care Med       Date:  1992       Impact factor: 17.440

9.  Risk factors for infection by Pseudomonas aeruginosa in patients with ventilator-associated pneumonia.

Authors:  J Rello; V Ausina; M Ricart; C Puzo; E Quintana; A Net; G Prats
Journal:  Intensive Care Med       Date:  1994       Impact factor: 17.440

10.  Molecular epidemiology of Pseudomonas aeruginosa in an intensive care unit.

Authors:  G Döring; M Hörz; J Ortelt; H Grupp; C Wolz
Journal:  Epidemiol Infect       Date:  1993-06       Impact factor: 2.451

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.